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 Bile acid homeostasis is achieved through an enterohe-
patic circulation. Canalicular secretion of bile acids through 
bile salt export pump (BSEP, ABCB11) is the rate-limiting 
step in the circulation ( 1, 2 ). Modulation of BSEP expres-
sion or function by inherited or acquired factors has pro-
found impact on biliary and intrahepatic bile acid levels. 
Indeed, impairment of BSEP function or expression has 
been directly linked to such diseases as progressive famil-
ial intrahepatic cholestasis type 2 ( 3–6 ), benign recurrent 
intrahepatic cholestasis ( 7–9 ), intrahepatic cholestasis of 
pregnancy ( 10, 11 ), drug-induced cholestasis ( 12 ), and liver 
cancer ( 6, 13, 14 ). 
 BSEP expression is coordinately regulated by distinct 
but related transactivation pathways ( 15–19 ), notably the 
bile acids/farnesoid X receptor (FXR, NR1H4) signaling 
pathway ( 15, 16 ). Activation of FXR by bile acids strongly 
induces BSEP expression in vitro and in vivo ( 15, 16 ). Such 
feed-forward regulation of BSEP by bile acid/FXR is con-
sidered a major mechanism for preventing excessive ac-
cumulation of toxic bile acids in hepatocytes. Two FXR 
genes, FXR  and FXR  , have been identifi ed ( 20–22 ). 
FXR  is functional in all the species tested, while FXR  is 
a pseudogene in humans ( 22 ). Four isoforms of FXR  
(FXR  1–4) have been identifi ed as a result of alternative 
promoter and splicing ( 23, 24 ). Isoforms FXR  1 and FXR  2 
are predominantly expressed in the liver and adrenal 
glands, whereas isoforms FXR  3 and FXR  4 are primarily 
expressed in the kidneys and intestines in humans ( 23 ). 
 Abstract  Expression of bile salt export pump (BSEP) is 
regulated by the bile acid/farnesoid X receptor (FXR) sig-
naling pathway. Two FXR isoforms, FXR  1 and FXR  2, 
are predominantly expressed in human liver. We previously 
showed that human BSEP was isoform-dependently regu-
lated by FXR and diminished with altered expression of 
FXR  1 and FXR  2 in patients with hepatocellular car-
cinoma. In this study, we demonstrate that FXR  1 and 
FXR  2 regulate human BSEP through two distinct FXR re-
sponsive elements (FXRE): IR1a and IR1b. As the predom-
inant regulator, FXR  2 potently transactivated human 
BSEP through IR1a, while FXR  1 weakly transactivated 
human BSEP through a newly identifi ed IR1b. Relative ex-
pression of FXR  1 and FXR  2 affected human BSEP ex-
pression in vitro and in vivo. Electrophoretic mobility shift 
and chromatin immunoprecipitation assays confi rmed the 
binding and recruitment of FXR  1 and FXR  2 to IR1b 
and IR1a. Sequence analysis concluded that IR1b was com-
pletely conserved among species, whereas IR1a exhibited 
apparent differences across species. Sequence variations 
in IR1a were responsible for the observed species differ-
ence in BSEP transactivation by FXR  1 and FXR  2.  In 
conclusion, FXR regulates BSEP in an isoform-dependent 
and species-specifi c manner through two distinct FXREs, 
and alteration of relative FXR isoform expression may be 
a potential mechanism for FXR to precisely regulate human 
BSEP in response to various physiological and pathologi-
cal conditions. —Song, X., Y. Chen, L. Valanejad, R. Kaimal, 
B. Yan, M. Stoner, and R. Deng.  Mechanistic insights into 
isoform-dependent and species-specifi c regulation of bile 
salt export pump by farnesoid X receptor.  J. Lipid Res. 
 2013.  54:  3030–3044. 
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Isoform and species-specifi c regulation of BSEP by FXR 3031
IR1b (ATG C C C CT TT ACT), and the half ER2 site ( AA CCCT), 
respectively (mutated nucleotides are underlined). Rat bsep pro-
moter mutants prBSEP(-2kb)-IR1a-Mut, prBSEP(-2kb)-IR1b-Mut, 
prBSEP(-2kb)-IR1ab-Mut, and prBSEP(-2kb)-ER2-Mut were pre-
pared by mutating the IR1a, IR1b, IR1a and IR1b, and the half 
ER2 site using prBSEP(-2kb) as templates. Three, four, and three 
nucleotides were mutated in IR1a ( G GG A CATTGA T CT), IR1b 
(ATG C C C CT TT ACT), and the half ER2 site ( AAA ACT), respec-
tively. Replacement of human IR1a (hIR1a) with mouse/rat IR1a 
(m/rIR1a) was achieved through mutagenesis using phBSEP(-2.6kb) 
as the template, resulting in a chimeric reporter phBSEP(-2.6kb)-m/
rIR1a. Chimeric reporter prBSEP(-2kb)-hIR1a was made through 
mutagenesis by replacing the mouse/rat IR1a (m/rIR1a) with the 
human IR1a (hIR1a) using prBSEP(-2kb) as the template. All the 
mutants were subjected to sequence confi rmation. 
 Immunohistofl uorescence 
 Normal human liver tissue sections embedded in paraffi n 
(ab4348) were obtained from Abcam (Cambridge, MA). Deparaf-
fi nization, antigen retrieval, and immune staining of the sections 
were carried out basically according to the protocol recommended 
by the manufactures. Nonspecifi c binding was blocked by using 
5% BSA in 1× TBS containing 0.1% TX-100 for 2 h on shaker at 
room temperature. Three types of primary antibodies (Abs) were 
applied to individual slides, including rabbit anti-FXR  1-specifi c 
Abs (custom-made by the NeoBioLab, Woburn, MA), rabbit anti-
FXR Abs (sc-13063), and rabbit IgG (sc-2027, Santa Cruz Biotech-
nology) as negative controls. AlexaFluor 594 goat anti-rabbit Abs 
(A11012, Invitrogen) was used as the secondary Abs. The sections 
were then mounted under a glass cover slip using Vectashield 
mounting medium containing 1.5   g/ml DAPI (H-1500, Vector 
Laboratories, Burlingame, CA) as nuclei counterstaining. Images 
were captured under a confocal microscope at a magnifi cation 
of 40× (Zeiss AxioImager M2 Imaging System) with fl uorescent 
and differential interference contrast (DIC) settings. 
 Reporter luciferase assay 
 The reporter luciferase activity assays were carried out using the 
human hepatoma Huh 7 cells and rat hepatocellular carcinoma 
 We have recently showed that human BSEP expression 
was severely diminished in patients with hepatocellular 
carcinoma (HCC) and that such decreased expression of 
BSEP correlated with altered relative expression of FXR  1 
and FXR  2 ( 25 ). Similar to human BSEP, FXR  2 showed 
more potent activity than FXR  1 in transactivating other 
hepatic FXR targets, including human syndecan-1 and fi -
brinogens ( 26, 27 ), whereas mouse bsep and small het-
erodimeric partner (SHP) were regulated by FXR  1 and 
FXR  2 to similar degrees ( 24 ). Currently, the underlying 
mechanisms for such isoform-dependent and species-spe-
cifi c regulation of BSEP by FXR are not understood. 
 In this study, we demonstrate that FXR  1 and FXR  2 
transactivated human BSEP through two distinct FXR re-
sponsive elements (FXRE) that are inverted repeats spaced 
by one nucleotide (IR1): IR1b and IR1a, respectively. In ad-
dition to total FXR expression levels, relative expression of 
FXR  1 and FXR  2 affected human BSEP expression in vitro 
and in vivo. Further study revealed that sequence variations 
in IR1a were responsible for the observed species difference 
in transactivation of BSEP by FXR  1 and FXR  2. 
 EXPERIMENTAL PROCEDURES 
 Reagents and suppliers 
 Chemicals and reagents for cloning, site-directed mutagenesis, 
polymerase-chain reaction (PCR), gel-shift assays, cell cultures, 
transfection, and luciferase assays were described previously ( 28 ). 
 Plasmid constructs 
 Human, mouse, and rat bsep promoter reporters and mu-
tants, including phBSEP (-2.6kb), pmBSEP(-2.6kb), prBSEP(-2kb), 
phBSEP(-125b), and phBSEP(-2.6kb)-IR1a-Mut, were prepared 
previously ( 18, 28, 29 ). Human pTK-3xhIR1a, mouse/rat pTK-
3xm/rIR1a, and pTK-3xIR1b reporters were constructed by clon-
ing three copies of the corresponding element into pTK-Luc 
vector. Element reporters pGL3/p-2xhIR1a and pGL3/p-2xhER2/
IR1a were prepared by cloning two copies of IR1a and ER2/IR1a 
element in human BSEP promoter into the pGL3/p vector, re-
spectively. Element reporters, including pElement 1–6, were gen-
erated by cloning the corresponding element into the pGL3/p 
vector. Expression plasmids for human nuclear receptors FXR  2 
and FXR  1 were kindly provided by Dr. Matthew Stoner and Dr. 
David Mangelsdorf (University of Texas Southwestern Medical 
Center), respectively. 
 Liver samples 
 Snap-frozen healthy human liver samples were obtained 
through the Mid-Atlantic Division of the Cooperative Human 
Tissue Network (CHTN) (University of Virginia). The protocol 
for using human tissues was approved by the Institutional Review 
Board (IRB) at the University of Rhode Island. 
 Site-directed mutagenesis 
 Mutations were introduced into the templates using a Quick-
Change site-directed mutagenesis kit according to the manufac-
turer’s manual (Stratagene) ( 29 ). Human BSEP promoter mutants 
phBSEP(-2.6kb)-IR1b-Mut, phBSEP(-2.6kb)-IR1ab-Mut, and 
phBSEP(-2.6kb)-ER2-Mut were prepared by mutating the IR1b, 
IR1a and IR1b, and half ER2 (everted repeat separated by two 
nucleotides) sites using phBSEP(-2.6kb) as a template. Six, four, 
and two nucleotides were mutated in IR1a (G ACG C G T GA ATTC), 
 Fig.  1. Transactivation of BSEP by FXR  1 and FXR  2. Human, 
mouse, and rat bsep promoter reporters phBSEP(-2.6kb), pmBSEP
(-2.6kb), and prBSEP(-2kb) were cotransfected into human hepa-
toma Huh 7 cells with either FXR  1 or FXR  2 expression plasmid, 
followed by treatment of the transfected cells with vehicle DMSO 
(0.1%) or CDCA (10   M) for 30 h. Reporter transactivation levels 
as luciferase activities were detected with a dual-luciferase reporter 
assay system. The fi refl y luminescence was normalized based on 
the  Renilla luminescence signal. The data are presented as mean ± 
SD of at least three separate experiments. * P < 0.05 between DMSO 
and CDCA-treated cells (Student  t -test). 
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(-2.6kb), phBSEP(-2.6kb)-IR1a-Mut, phBSEP(-2.6kb)-IR1b-Mut, 
or phBSEP(-2.6kb)-IR1ab-Mut. Sixteen hours posttransfection, 
cells were treated with 10   M CDCA for 24 h. Chromatin prepa-
ration and immunoprecipitation (ChIP) assays were performed 
essentially as described previously ( 28 ). A test set of primers, 
BSEP(-260b) and pGL4-R(122), fl anking IR1a and IR1b were 
used to amplify a 462 bp fragment encompassing sequence from 
nucleotides   260 to +80 in the BSEP promoter and 122 nucle-
otides in the luciferase gene. A negative control set of primers 
was included in the assays ( 28 ). 
 Living imaging with in vivo imaging system 
 Sixteen female CD-1 mice between ages 5 and 8 weeks were 
obtained from Charles River Laboratory (Wilmington, MA) and 
randomly divided into four groups. Each group of mice was 
(HCC) L0 cells (kindly provided by Dr. Jonathan Reicher, Brown 
University) in a 24-well plate as described previously ( 28 ). 
 Electrophoretic mobility shift assays 
 Nuclear extracts of Huh 7 cells transfected with FXR  1 or 
FXR  2 were prepared using the NE-PER Nuclear and Cytoplas-
mic Extraction kit (Pierce). The electrophoretic mobility shift 
assays (EMSA) were performed using the LightShift Chemilumi-
nescent EMSA kit (Pierce) as described ( 17 ). Supershift assays 
were carried out using polyclonal Abs against human FXR (sc-
13063, Santa Cruz Biotechnologies). 
 Chromatin immunoprecipitation assays 
 Huh 7 cells seeded in 6-well plates were cotransfected with 
400 ng of either FXR  1 or FXR  2 and either 400 ng phBSEP
 Fig.  2. The effects of relative expression levels of FXR  1 and FXR  2 on BSEP expression in human liver tissues and Huh 7 cells. (A) 
mRNA expression levels of BSEP and total FXR in healthy human liver tissues were determined by TaqMan real-time PCR and plotted 
against FXR  1/FXR  2 ratios using SigmaPlot version 11.0. The cycle time (Ct) values Ct24.92 for FXR and Ct27.12 for BSEP of one tissue 
sample were designated as a relative unit 1. (B) A series of mixtures of FXR  1 and FXR  2 plasmid DNA in various FXR  1/FXR  2 ratios 
(from 1.0, 1.2, 1.4, 1.6 to 1.8) with a constant amount of total FXR at 10, 25, or 50 ng were cotransfected with human BSEP promoter re-
porter in Huh 7 cells, followed by treatment of the transfected cells with CDCA for 30 h and subsequent detection of luciferase activity. 
FXR  1/FXR  2 ratios were plotted against total FXR and BSEP promoter transactivation as luciferase activities using SigmaPlot version 
11.0. The left fi gure shows the level and position of each individual sample in the 3D diagram. The right fi gure is the smooth 3D model 
based on the data shown on the left. 
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associated with dysregulation of BSEP in patients with 
HCC ( 25 ). In this study, we extended such fi nding by test-
ing FXR isoform-mediated transactivation of BSEP from 
three species, including human, mouse, and rat. Consis-
tent with our previous fi ndings, FXR  2 exhibited much 
more potent activity in transactivating human BSEP than 
FXR  1 in the presence or absence of endogenous FXR 
agonist chenodeoxycholic acid (CDCA) ( Fig. 1 ).  In contrast, 
both mouse and rat bsep were transactivated by FXR  1 
and FXR  2 in comparable levels ( Fig. 1 ). The results dem-
onstrated that human BSEP was differentially regulated by 
FXR  1 and FXR  2 with FXR  2 being the predominant 
regulator, whereas mouse and rat bsep were similarly trans-
activated by the two isoforms. 
 Relative FXR isoform and total FXR expression affected 
the expression levels of human BSEP 
 In our previous studies, it was shown that the relative 
expression levels of FXR  1 and FXR  2 correlated with 
BSEP expression ( 25 ). In this study, the comprehensive 
relationships among FXR isoforms, total FXR expression, 
and BSEP expression were further investigated. As shown 
in  Fig. 2A ,  the expression levels of BSEP and total FXR in 
healthy human liver samples were plotted against FXR  1/
FXR  2 ratios using SigmaPlot 3D program. Over 27- and 
6-fold differences in BSEP and total FXR expression, re-
spectively, were detected among the liver samples. Consis-
tent with FXR’s transactivating role in BSEP regulation, 
BSEP expression increased along with increase in total 
FXR. However, the relationship between FXR  1/FXR  2 
ratios and BSEP expression did not exhibit a single trend 
( Fig. 2A ). At higher levels of total FXR, as expected, BSEP 
expression decreased as the FXR  1/FXR  2 ratios in-
creased. However, at lower levels of total FXR, BSEP ex-
pression increased as the FXR  1/FXR  2 ratios increased. 
The data thus indicated that BSEP expression in human 
hydrodynamically injected with phBSEP(-2.6kb), prBSEP(-2kb), 
phBSEP(-2.6kb)-m/rIR1a, or prBSEP(-2kb)-hIR1a promoter re-
porter as described previously ( 25 ). Luciferase activities were de-
tected by living imaging with in vivo imaging system (IVIS) 48 h 
postinjection and captured by a CCD camera with an exposure 
time of 45 s ( 25 ). The animal protocols were approved by the 
Institutional Animal Care and Use Committee (IACUC) at the 
University of Rhode Island (URI) and followed the guidelines 
outlined in the National Institutes of Health Guide for the Care 
and Use of Laboratory Animals. 
 Quantitative real-time PCR 
 Total RNA extraction from 14 healthy human and 8 CD-1 mice 
liver tissues and subsequent cDNA synthesis and TaqMan real-
time PCR detection for total FXR and BSEP were carried out as 
reported ( 17, 25 ). 
 Semiquantifi cation of FXR  1 and FXR  2 
 By using human liver cDNA samples as templates, the relative 
FXR  1 and FXR  2 mRNA levels were determined by the semi-
quantifi cation methods described previously ( 25 ). 
 Statistical analysis 
 Student  t -test was applied to pair-wise comparison to deter-
mine the statistical signifi cance. Nonparametric Mann-Whitney 
test was used for pair-wise comparison for nonnormally distrib-
uted data. Values of 0.05 or less were considered signifi cant. 
 RESULTS 
 Isoform-dependent and species-specifi c regulation of 
BSEP transactivation by FXR 
 Four FXR  isoforms (FXR  1–4) have been identifi ed, 
with predominant expression of FXR  1 and FXR  2 in the 
liver ( 23, 24 ). Our previous study showed that human 
BSEP was regulated by FXR in an isoform-dependent 
manner and that alteration of isoform expression was 
 Fig.  3. Expression and localization of FXR  1 and total FXR in human liver tissues. Liver sections were 
subjected to immunohistofl uorescent assays. FXR  1- and FXR-specifi c Abs and rabbit IgG as negative con-
trols were used as primary Abs. Goat anti-rabbit Abs labeled with AlexaFluor 594 was used as the secondary 
Abs. Mounting medium containing DAPI (1.5   g/ml) was used as nuclei counterstaining. Images were cap-
tured under a confocal microscope at a magnifi cation of 40× with both fl uorescent and DIC settings. 
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determining human BSEP transactivation and that its ef-
fects were infl uenced by the total FXR expression levels. 
 Expression and localization of FXR  1 and total FXR 
protein in human liver tissue 
 Immunohistofl uorescence was carried out to investigate 
the expression and localization of total FXR and FXR  1. In 
our attempt to generate FXR isoform-specifi c Abs, antise-
rum raised against FXR  1-specifi c peptide detected FXR  1 
protein specifi cally, whereas antiserum raised against FXR  2-
specifi c peptide recognized both FXR  2 and FXR  1 pro-
tein (data not shown) because there are only four extract 
amino acids inserted in FXR  1 compared with FXR  2. 
Therefore, FXR  1-specifi c Abs and Abs recognizing both 
FXR  1 and FXR  2 were used in the immunohistofluo-
r escent assays. As shown in  Fig. 3 ,  minimal red fl uorescent 
signals were detected with rabbit IgG as negative controls 
while FXR  1 and total FXR proteins were readily detected 
with FXR  1- and FXR-specifi c Abs. Both FXR  1 and total 
FXR proteins were predominantly present in the cyto-
plasm. As expected, relatively weaker signals were detected 
with FXR  1-specifi c Abs than with FXR-specifi c Abs. 
 Isoform-dependent transactivation of human BSEP 
by FXR was not due to a difference in 
ligand-mediated activation 
 In the previous experiments, the potent endogenous 
FXR agonist CDCA was used in evaluating human BSEP 
transactivation by FXR isoforms. To determine whether 
FXR  1- and FXR  2 -mediated differential transactivation 
of human BSEP is related to specifi c FXR ligands, a series 
of FXR endogenous and exogenous ligands were tested 
for their ability to induce FXR  1- and FXR  2-mediated 
transactivation of human BSEP. The ligands tested include 
six endogenous bile acids, including cholic acid (CA), 
CDCA, deoxycholic acid (DCA), lithocholic acid (LCA), 
ursodeoxycholic acid (UDCA) and glycodeoxycholic acid 
(GDCA), a natural product guggulsterone, and two syn-
thetic FXR agonists GW4064 and T0901317. As shown in 
 Fig. 4A ,  all the FXR ligands exhibited similar FXR isoform-
dependent transactivation of human BSEP regardless their 
agonistic potency. FXR  2 consistently transactivated hu-
man BSEP at a much higher level than FXR  1 with each of 
the ligands. 
 In contrast to human BSEP, both mouse and rat bsep 
promoters exhibited comparable transactivation activities 
by FXR  1 and FXR  2, with slightly higher levels with 
FXR  2 in the presence of CDCA in Huh 7 cells ( Fig. 1 ). 
Considering the possibility that rat or mouse bsep may 
exhibit a different transactivation pattern by FXR  1 and 
FXR  2 in rat or mouse cells, rat bsep promoter reporter 
prBSEP(-2kb) was cotransfected with FXR  1 or FXR  2 in 
rat HCC L0 cells, followed by treatment with various FXR 
ligands. As shown in  Fig. 4B , consistent with the data from 
Huh 7 cells, FXR  1 and FXR  2 exhibited similar transac-
tivation levels with most FXR ligands, except for CDCA 
and LCA. FXR  2 transactivated rat bsep more potently 
than did FXR  1 with CDCA and LCA. However, it should 
be emphasized that the differences between FXR  2 and 
FXR  1 in transactivating human BSEP in Huh 7 cells were 
livers was dictated by the FXR  1/FXR  2 ratios as well as 
by total FXR expression levels. 
 To directly evaluate the effect of FXR  1/FXR  2 ratios 
at various total FXR levels on BSEP transactivation in vitro, 
a series of mixtures of FXR  1 and FXR  2 plasmid DNA in 
various ratios (from 1:1 to 1.8:1) at various amounts of total 
FXR (10, 25, or 50 ng) were cotransfected with the human 
BSEP promoter reporter in Huh 7 cells, followed by treat-
ment with CDCA. As shown in  Fig. 2B , a relationship pattern 
comparable to human liver samples ( Fig. 2A ) was observed 
in transfected Huh 7 cells. BSEP transactivation gradually 
decreased as the FXR  1/FXR  2 ratios increased at a high 
level of total FXR plasmid DNA (50 ng) but increased at a 
low level of total FXR plasmid DNA (10 ng). The minor dif-
ferences between the two data sets ( Fig. 2 ) may refl ect the 
fact that the sample size of human liver samples was rela-
tively small. Taken together, the results demonstrated that 
the ratio of FXR  1/FXR  2 played an important role in 
 Fig.  4. Transactivation of BSEP promoters by FXR  1 and FXR  2 
with various FXR ligands. (A) Human BSEP promoter reporter 
phBSEP(-2.6kb) and (B) rat bsep promoter reporter prBSEP(-2kb) 
were cotransfected into human hepatoma Huh 7 cells and rat HCC 
L0 cells, respectively, with FXR  1 or FXR  2, followed by treatment 
of transfected cells with various endogenous and exogenous FXR 
ligands, including CA (10   M), CDCA (10   M), DCA (10   M), 
LCA (10   M), UDCA (10   M), GDCA (10   M), GW4064 (1   M), 
GUG (10   M), and T0901317 (1   M). Thirty hours post treatment, 
reporter transactivation levels as luciferase activities were detected 
with a dual-luciferase reporter assay system. The fi refl y lumines-
cence was normalized based on the  Renilla luminescence signal. 
The data are presented as mean ± SD of at least three separate ex-
periments. * P < 0.05 between FXR  1 and FXR  2-transfected cells 
(Student  t -test). 
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 Previous studies revealed that half nuclear receptor 
binding site and ER2 (everted repeat separated by two 
nucleotides) are commonly found adjacent to the IR1 
( 30 ). A half ER2 motif was identifi ed immediately up-
stream the IR1a ( Fig. 5C ). Inclusion of the motif in hER2/
IR1a reporter signifi cantly enhanced FXR  2-mediated trans-
activation ( Fig. 5C ), indicating that the half ER2 motif 
is required for maximal transactivation of human BSEP 
by FXR  2. However, FXR  1 still failed to transactivate the 
hER2/IR1a reporter, suggesting that FXR  1 must regu-
late human BSEP through an additional FXRE. 
 FXR  1 transactivated human BSEP through IR1b, a 
newly identifi ed FXRE 
 To determine whether the potential additional FXRE 
is present in the minimal human BSEP promoter, the 
resultant phBSEP(-125b) reporter was cotransfected with 
FXR  1, followed by treatment with DMSO or CDCA. As 
shown in  Fig. 6A ,  similar to the full-length promoter re-
porter phBSEP(-2.6kb), FXR  1 signifi cantly transactivated 
the minimal promoter reporter, indicating that the poten-
tial additional FXRE is located in the minimal promoter 
region. 
 Since no FXREs were predicted by bioinformatic analy-
sis in the region, a series of element reporters covering the 
entire region were constructed and evaluated for their 
ability to respond to FXR  1 ( Fig. 6B, C ). Reporters pEle-
ment 1 and 4 exhibited signifi cant induction of activity in 
response to CDCA in the presence of FXR  1, whereas no 
induction was detected with other reporters. The data thus 
mapped a new functional FXRE (named IR1b) in the over-
lapped region between pElement 1 and 4 at positions from 
much more striking than those with rat bsep in rat HCC 
L0 cells. FXR  2 was 27.1- or 18.9-fold more potent than 
FXR  1 in transacting human BSEP in Huh 7 cells in the 
presence of CDCA or LCA, whereas only 2.6- or 4.1-fold 
differences were observed between FXR  2 and FXR  1 in 
transactivating rat bsep in L0 cells with CDCA or LCA. 
 Taken together, the data indicated that the isoform-
dependent transactivation of human BSEP by FXR was not 
due to a difference between FXR  1 and FXR  2 in ligand 
binding or ligand-mediated activation. On the other hand, 
FXR  1 and FXR  2 transactivated rat bsep comparably 
with most of the FXR ligands. 
 Isoform-dependent and species-specifi c transactivation 
of BSEP by FXR was due to a difference in FXRE in 
BSEP promoters 
 Early studies identifi ed an FXRE (named IR1a) in the 
BSEP promoter ( 15, 16 ). To determine whether the isoform-
dependent and species-specifi c transactivation of BSEP is 
due to a differential activation of the IR1a by FXR  1 and 
FXR  2, human and mouse/rat IR1a (hIR1a and m/rIR1a) 
reporters were constructed and tested for their ability to 
support FXR  1 or FXR  2 transactivation. It should be 
mentioned that the IR1a sequences are completely con-
served in mouse and rat bsep promoters. As shown in 
 Fig. 5A ,  FXR  2 signifi cantly transactivated hIR1a reporter, 
whereas no transactivation was detected in cells transfected 
with FXR  1. Conversely, both FXR  1 and FXR  2 strongly 
transactivated m/rIR1a reporter ( Fig. 5B ). The results thus 
demonstrated that hIR1a only supported FXR  2 transacti-
vation, while m/rIR1a was capable of mediating both FXR  1 
and FXR  2 transactivation. 
 Fig.  5. Isoform-dependent and species-specifi c transactivation of IR1a reporters by FXR  1 and FXR  2. 
(A) Human BSEP IR1a reporter pTK-3xhIR1a, (B) mouse/rat bsep IR1a reporter pTK-3xm/rIR1a, and (C) 
human BSEP ER2/IR1a reporter pGL3/p-2xhER2/IR1a were cotransfected with FXR  1 or FXR  2, followed 
by treatment of the cells with DMSO (0.1%) or CDCA (10   M) for 30 h. Reporter luciferase activities were 
detected with the dual-luciferase reporter assay system. The data are presented as mean ± SD of at least three 
repeated experiments. * P < 0.05 between DMSO and CDCA-treated cells (Student  t -test). 
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  97b to   85b ( Fig. 6D ). The IR1b was physically close to 
IR1a (18 bases from each other). To confi rm that the 
newly identifi ed IR1b is functional in supporting FXR  1 
transactivation, IR1b reporter pTK-3xIR1b was constructed 
and tested. As shown in  Fig. 6D , FXR  1 moderately trans-
activated IR1b reporter in the presence of CDCA, confi rm-
ing that FXR  1 regulates human BSEP through IR1b. 
 Mutational analysis of IR1a and IR1b in supporting 
FXR  1- and FXR  2-mediated transactivation of human 
and rat bsep 
 To determine the relative contribution of IR1a, IR1b, 
and the half ER2 sites to the transactivation of human and 
rat bsep by FXR  1 and FXR  2, mutational analyses were 
performed in those elements. Double mutation in IR1a 
and IR1b was also introduced. 
 For human BSEP, similar to the IR1a and IR1b double 
mutant, IR1b mutant completely lost its ability to respond 
to FXR  1 ( Fig. 7A ),  suggesting that FXR  1 regulates 
human BSEP through IR1b. Although mutation in IR1a 
decreased FXR  1-mediated transactivation, signifi cant 
induction remained ( Fig. 7A ). More signifi cantly, the fold 
induction by CDCA over DMSO was comparable between 
IR1a mutant and wild-type (wt) (13.1 versus 11.3), indicat-
ing that IR1a is required for basal activity but not FXR  1-
mediated transactivation. Conversely, mutation in IR1a 
almost entirely abolished FXR  2-mediated transactivation 
as did the double mutant ( Fig. 7B ), consistent with regula-
tion of human BSEP by FXR  2 through IR1a. Similarly, 
the IR1b mutant retained the ability to respond to CDCA 
in the presence of FXR  2 with almost identical fold induc-
tions as the wt (7.9 versus 7.4) ( Fig. 7B ). Mutation in the 
half ER2 motif markedly reduced FXR  2- but not FXR  1-
mediated transactivation ( Fig. 7A, B ). Taken together, the 
data demonstrated that FXR  1 and FXR  2 transactivated 
human BSEP through IR1b and IR1a, respectively, and 
that the ER2 motif is required for maximal FXR  2 
transactivation. 
 Similar mutational analyses were performed with rat 
bsep promoter to evaluate species differences. As shown in 
 Fig. 7C , mutation in IR1a or IR1b resulted in a decrease in 
FXR  1-mediated transactivation. However, signifi cant ac-
tivation by CDCA remained for both mutants. As expected, 
the double mutant almost completely lost its ability to re-
spond to CDCA. The results indicated that different from 
human BSEP, FXR  1 regulated rat bsep through both 
IR1a and IR1b. Conversely, mutation in IR1a almost totally 
abolished FXR  2-mediated transactivation as did the dou-
ble mutant, indicating that FXR  2 regulates rat bsep 
through IR1a. Although mutation in IR1b decreased 
FXR  2-mediated transactivation, signifi cant induction by 
CDCA was detected with a comparable fold induction to 
the wt (7.7 versus 6.5) ( Fig. 7D ), indicating that similar to 
human BSEP, IR1b is required for basal activity but not 
for FXR  2-mediated transactivation. Mutation in the half 
ER2 site had no detectable effect on FXR  1- and FXR  2-
mediated transactivation ( Fig. 7C, D ), suggesting that dif-
ferent from human BSEP, the half ER2 in rat bsep does 
not play any roles in mediating FXR  2 transactivation. 
 Fig.  6. FXR  1 transactivated human BSEP through a newly 
identifi ed FXRE, IR1b. (A) Full-length and minimal human BSEP 
promoter reporters phBSEP(-2.6kb) and phBSEP(-125b) were 
cotransfected with FXR  1 in Huh 7 cells. Sixteen hours posttrans-
fection, cells were treated with DMSO (0.1%) and CDCA (10   M) 
for 30 h, followed by detection luciferase activities with dual-lu-
ciferase reporter assay system. The data are presented as mean ± 
SD of at least three repeated experiments. (B) A diagram showing 
the positions of the six elements in the minimal promoter region. 
(C) The six elements were cloned into the pGL3/p-Luc vector, re-
sulting in six element reporters, pElement 1 to 6. Activation of the 
six element reporters by FXR  1 in the presence of CDCA (10   M) 
was detected by the dual-luciferase reporter assay system. The data 
are presented as mean ± SD of at least three repeated experiments. 
* P < 0.05 between DMSO and CDCA-treated cells (Student  t -test). 
(D) The location and sequence of the newly identifi ed IR1b are 
shown in the upper panel. Transactivation of hIR1a and IR1b re-
porters by FXR  1 are presented in the lower panel. Reporters pTK-
3xhIR1a and pTK-3xIR1b were cotransfected into Huh 7 cells with 
FXR  1, followed by treating the cells with DMSO (0.1%) or CDCA 
(10   M) for 30 h prior to detection of luciferase activities as de-
scribed in (A). * P < 0.05 between DMSO and CDCA-treated cells 
(Student  t -test). 
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 Fig.  7. Mutational analysis of IR1a and IR1b in BSEP promoters. Four human BSEP promoter mutants 
with mutation in IR1a, IR1b, the half ER2 site, or both IR1a and IR1b were made using human BSEP pro-
moter reporter phBSEP(-2.6kb) as parental template, resulting in mutants phBSEP(-2.6kb)-IR1a-Mut, 
phBSEP(-2.6kb)-IR1b-Mut, phBSEP(-2.6kb)-IR1ab-Mut, and phBSEP(-2.6kb)-ER2-Mut. Four equivalent mu-
tants were constructed using rat bsep promoter reporter prBSEP(-2kb) as parental template, resulting in 
prBSEP(-2kb)-IR1a-Mut, prBSEP(-2kb)-IR1b-Mut, prBSEP(-2kb)-IR1ab-Mut, and prBSEP(-2kb)-ER2-Mut. 
The four human BSEP promoter mutants and wt were cotransfected with (A) FXR  1 or (B) FXR  2 into 
Huh 7 cells. The four rat bsep promoter mutants and wt were cotransfected with (C) FXR  1 or (D) FXR  2. 
Sixteen hours posttransfection, cells were treated with DMSO (0.1%) or CDCA (10   M) for 30 h, followed 
by detection of luciferase activities by the dual-luciferase reporter assay system. The data are presented as 
mean ± SD of at least three repeated experiments. * P < 0.05 between DMSO and CDCA-treated cells (Stu-
dent  t -test). The fold inductions by CDCA over DMSO are presented on the top of the bars. 
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 Binding of FXR  1 and FXR  2 to IR1a and IR1b in vitro 
 To determine whether FXR isoforms differentially bind 
to IR1a and IR1b in vitro, a series of EMSA assays were per-
formed. With hIR1a and m/rIR1a probes, two distinct bands 
were shifted for both FXR  1 and FXR  2, indicating that 
two DNA/protein complexes were formed ( Fig. 8A , B ).  To 
determine which band represents the specifi c binding of 
FXR  1 or FXR  2 to the probe, competition assays were 
carried out. The dominant bottom band was completely 
competed out by 10× unlabeled wt but not by mutated 
hIR1a or m/rIR1a oligonucleotide, indicating that the 
bottom band represented the probe-specifi c complex. To 
confi rm that FXR  1 or FXR  2 is part of the complex, 
supershift assays with Abs against FXR were performed. 
Preincubation of FXR Abs with nuclear extracts mark-
edly decreased the shifted band, suggesting that the bind-
ing of FXR Abs to FXR interferes with its binding to the 
hIR1a or m/rIR1a probe, decreasing the formation of 
the DNA/FXR complexes. The data thus demonstrated 
that both FXR  1 and FXR  2 bound to hIR1a or m/rIR1a 
abundantly in vitro. The abundant binding of FXR  1 to 
hIR1a was not expected since FXR  1 failed to transacti-
vate hIR1a reporter. 
 With IR1b as a probe, two similar bands were shifted 
with FXR  1 and FXR  2. Competition EMSA assays con-
cluded that the bottom band was the specifi c one. Incuba-
tion of FXR Abs with the complex resulted in a supershifted 
band ( Fig. 8C ), indicating that FXR is part of the complex. 
It should be emphasized that although similarly shifted 
patterns were observed for both FXR  1 and FXR  2, the 
bands shifted or supershifted with FXR  1 were much 
more abundant than those with FXR  2, suggesting that 
FXR  1 has a higher binding affi nity to IR1b than does 
FXR  2. 
 FXR  1 and FXR  2 were specifi cally recruited to 
IR1b and IR1a, respectively, in human BSEP promoter 
in intact cells 
 Since IR1a and IR1b are located so close to each other, 
it was challenging to distinguish FXR recruitment to each 
individual site on the endogenous BSEP promoter. We 
used human BSEP promoter reporter wt and mutants to 
perform ChIP assays. Chromatins were prepared from 
Huh 7 cells cotransfected with FXR  1 or FXR  2 with hu-
man BSEP promoter wt, IR1a, IR1b, or IR1ab mutant. With 
FXR  1, a PCR band was readily detected in cells transfected 
 Fig.  8. Binding of FXR  1 and FXR  2 to IR1a and IR1b in vitro. EMSAs were performed using (A) human hIR1a, (B) mouse/rat m/
rIR1a, or (C) IR1b as probe. Nuclear extracts were prepared from Huh 7 cells transfected with FXR  1 or FXR  2. The specifi city of the 
binding was established with competition assays using competing oligonucleotides, including unlabeled or mutated probe with 10× con-
centration. Identifi cation of FXR protein in the shifted complex was carried out by supershift assays using polyclonal Abs against human 
FXR. The shifted bands representing the specifi c binding of FXR to the probe or FXR Abs to FXR/DNA complex are indicated by 
arrows. 
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indicated that FXR  1 competitively bound to IR1a with 
FXR  2 in the IR1a element reporter, which is consistent 
with the data from EMSA ( Fig. 8A ). The results also indi-
cated that no competitive binding of FXR  1 to IR1a oc-
curred in the full-length promoter, which is consistent with 
the data from the ChIP assays ( Fig. 9A ). Such discrepancy 
in FXR  1’s effects on FXR  2-mediated transactivation of 
IR1a element and full-length promoter indicated that the 
context of IR1a played a determinant role in responding 
to FXR  1. It was thus concluded that in the content of full-
length promoter , FXR  1 and FXR  2 transactivated human 
BSEP independently through IR1b and IR1a, respectively 
and that BSEP expression levels were predominately de-
termined by FXR  2. 
 Combining the data from transactivation, mutational 
analysis, EMSA and ChIP assays, it was concluded that 
FXR  1 and FXR  2 regulated human BSEP independently 
through IR1b and IR1a. On the other hand, mouse and 
rat bsep are regulated by FXR  1 through both IR1a and 
IR1b and by FXR  2 through IR1a ( Fig. 10C ). 
 Sequence differences between hIR1a and m/rIR1a 
were primarily responsible for the species-specifi c 
transactivation of BSEP by FXR  1 and FXR  2 
 Sequence alignment of IR1a and IR1b in BSEP promot-
ers from seven species including human, pongo pygmaeus, 
pan troglodytes, horse, dog, rat, and mouse revealed that 
IR1b was completely conserved ( Fig. 11A ),  indicating the 
with wt promoter when the chromatins were immunopre-
cipitated with anti-FXR Abs but not with IgG ( Fig. 9A ). 
 More importantly, a PCR band with a relatively weaker sig-
nal was also detected in cells transfected with IR1a mutant. 
In contrast, no obvious bands were detected in cells trans-
fected with either IR1b mutant or IR1ab double mutant 
( Fig. 9A ). The data thus established that FXR  1 was spe-
cifi cally recruited to IR1b but not IR1a in intact Huh 7 
cells. On the other hand, with FXR  2, a PCR band was 
readily detected in cells transfected with wt and IR1b mu-
tant, whereas no signals were detected in cells transfected 
with IR1a and IR1ab double mutant ( Fig. 9B ). The data 
thus demonstrated that FXR  2 was specifi cally recruited 
to IR1a but not IR1b. 
 FXR  1 and FXR  2 acted independently in 
transactivating human BSEP 
 To investigate whether FXR  1 and FXR  2 have additive 
or competitive effects on the transactivation of human BSEP 
IR1a element reporter and full-length promoter, increas-
ing amounts of FXR  1 were cotransfected with a constant 
amount of FXR  2, followed by detection of the transacti-
vation levels. As shown in  Fig. 10A ,  FXR  1 competitively 
decreased FXR  2-mediated transactivation in cells trans-
fected with IR1a element reporter pGL3/p-2xhIR1a. In 
contrast, FXR  1 had minimal effects on FXR  2-mediated 
transactivation of the full-length promoter reporter phBSEP
(-2.6kb), even at the highest dose ( Fig. 10B ). The results 
 Fig.  9. Recruitment of FXR  1 and FXR  2 to IR1a and IR1b in intact cells. ChIP assays were carried out 
using chromatins prepared from Huh 7 cells cotransfected with (A) FXR  1 or (B) FXR  2 with human BSEP 
promoter reporter wt, IR1a, IR1b, or IR1ab double mutant. After immunoprecipitated with anti-FXR Abs or 
IgG as negative control, recruitment of FXR  1 or FXR  2 to IR1a or IR1b was detected by PCR using a set of 
primers, BSEP(-260b) and pGL-R(122), fl anking the two IR1 sites in the reporter plasmid DNA. A negative 
control primer set, BSEP(-995b) and BSEP(-805b), was used to amplify a fragment approximately 700b up-
stream the IR1 sites. Input chromatin DNA was included as a positive PCR control. 
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was replaced with the IR1a from other species were con-
structed and tested for their ability to respond to FXR  1 and 
FXR  2. As shown in  Fig. 11B , replacement of the hIR1a in 
the human BSEP promoter reporter phBSEP(-2.6kb) with 
m/rIR1a resulted in a strong transactivation of the chimeric 
promoter reporter phBSEP(2.6kb)-m/rIR1a by both FXR  1 
and FXR  2, a pattern comparable to mouse or rat promoter 
wt ( Fig. 1 ). On the other hand, the reciprocal chimera 
prBSEP(-2kb)-hIR1a in which the m/rIR1a of rat bsep pro-
moter reporter prBSEP(-2kb) was replaced with human hIR1a 
exhibited an isoform-dependent transactivation by FXR  1 
and FXR  2 as human BSEP promoter wt ( Fig. 11C ). 
 To further confi rm the results, the wt and chimeric pro-
moter reporters were injected into mice, and their transacti-
vation activities in vivo were evaluated by IVIS living imaging. 
As shown in  Fig. 11D , strong luciferase signals were detected 
in mice injected with wt rat bsep promoter reporter prBSEP(-
2.0kb), while no detectable signals were observed in mice re-
ceived wt human BSEP promoter reporter phBSEP(-2.6kb), 
indicating that rat bsep promoter has much stronger activity 
than human BSEP promoter. Replacement of mouse/rat 
IR1a with human hIR1a in prBSEP(-2.0kb)-hIR1a markedly 
reduced the signal compared with wt rat bsep promoter re-
porter. On the other hand, substitution of the human IR1a 
with mouse/rat m/rIR1a in phBSEP(-2.6kb)-m/rIR1a re-
sulted in noticeable elevation of luciferase signals compared 
with wt human BSEP promoter reporter. Taken together, the 
data fi rmly established that the sequence differences in IR1a 
were primarily responsible for the species-specifi c regulation 
of BSEP by FXR  1 and FXR  2. 
 To determine whether the observed differences in BSEP 
promoter activities between mouse and human is refl ected 
by the endogenous BSEP transcription levels, the BSEP 
mRNA levels in human and mouse liver tissues were quan-
tifi ed by real-time PCR with GAPDH levels as internal con-
trols. As shown in  Fig. 11E , the mRNA level of mouse bsep 
was signifi cantly higher than that of human BSEP. The 
data thus demonstrated that mouse bsep was transcribed 
at a much higher level than human BSEP in vivo. 
 DISCUSSION 
 As the limiting step in bile acid enterohepatic circula-
tion, canalicular effl ux of bile acids by BSEP is tightly regu-
lated by the bile acids/FXR signaling pathway. In our 
previous study, it was found that human BSEP was isoform-
dependently regulated by FXR, with FXR  2 being the 
predominant regulator. The relative expression of FXR  1 
and FXR  2 was altered in HCC patients and associated 
with dysregulation of BSEP ( 25 ). Similar FXR isoform-
dependent transactivation has been reported for other 
FXR targets, including ileal bile acid-binding protein ( 24 ), 
fi brinogens ( 26 ), syndecan-1 ( 27 ), and   -crystallin ( 31 ). 
However, it is currently not understood how FXR  1 and 
FXR  2 exhibit different activity on those FXR targets. 
Based on EMSA data, it was postulated that FXR  2 had a 
higher binding affi nity than FXR  1 to the FXRE of the 
targets ( 24 ). Such notion is consistent with the fact that 
importance of the element in regulating BSEP expression. 
On the other hand, IR1a was less conserved with 62% se-
quence identity among those species. 
 To determine whether the species-specifi c regulation of 
BSEP by FXR  1 and FXR  2 is due to the differences in IR1a, 
two chimeric promoter reporters in which the authentic IR1a 
 Fig.  10. Interrelationship between FXR  1 and FXR  2. The ef-
fects of FXR  1 on FXR  2-mediated transactivation of (A) human 
IR1a element reporter pGL3/p-2xhIR1a and (B) full-length hu-
man BSEP promoter reporter phBSEP(-2.6kb) were investigated. 
Increasing amounts of FXR  1 were cotransfected with a constant 
amount of FXR  2 and pGL3/p-2xhIR1a or phBSEP(-2.6kb). Vec-
tor pcDNA5 plasmid DNAs were also cotransfected to obtain a con-
stant total plasmid DNA in each well. Sixteen hours posttransfection, 
cells were treated with DMSO (0.1%) or CDCA (10   M) for 30 h, 
followed by detection of luciferase activity. The data are presented 
as mean ± SD of at least three repeated experiments. (C) A dia-
gram summarizing FXR  1- and FXR  2-mediated transactivation 
of BSEP through IR1a and IR1b. In human, FXR  1 and FXR  2 
regulate BSEP exclusively through IR1b and hIR1a, respectively. 
In mouse and rat, FXR  1 is able to transactivate BSEP through 
both m/rIR1a and IR1b, whereas FXR  2 transactivates exclusively 
through m/rIR1a. 
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 Fig.  11. IR1b is completely conserved among species, whereas IR1a is primarily responsible for the species 
difference in transactivation of BSEP by FXR  1 and FXR  2. (A) Sequences of the IR1a and IR1b from seven 
species including mouse, rat, dog, cat, horse, primate, and human were aligned. The overall conservation 
percentages of IR1a and IR1b are indicated. (B) The hIR1a in human BSEP promoter reporter phBSEP(-2
.6kb) was replaced with mouse/rat m/rIR1a, generating a chimeric reporter pBSEP(-2.6kb)-m/rIR1a. (C) 
The rIR1a in rat bsep promoter reporter prBSEP(-2kb) was replaced with human hIR1a, resulting a chimeric 
reporter prBSEP(-2kb)-hIR1a. Human and rat bsep promoter wt and chimeric reporters were cotransfected 
with FXR  1 or FXR  2 into Huh 7 cells, followed by treatment of transfected cells with DMSO (0.1%) or 
CDCA (10   M) for 30 h. Reporter activities were detected by the dual-luciferase reporter assay system. The 
data are presented as mean ± SD of at least three repeated experiments. (D) Female CD-1 mice were randomly 
divided into four groups. Each group of mice was hydrodynamically injected with either phBSEP(-2.6kb), 
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prBSEP(-2kb), phBSEP(-2.6kb)-m/rIR1a, or prBSEP(-2kb)-hIR1a promoter reporter. Luciferase activities as 
luminescent signals were detected by living imaging IVIS 48 h postinjection and captured by a CCD camera 
with an exposure of 45 s. (E) BSEP mRNA levels in human and mouse liver tissues were quantifi ed by Taq-
Man real-time PCR. Using GAPDH mRNA levels as internal standards, the relative mRNA expression levels 
of BSEP in human and mouse liver tissues were compared. Median value of each group is indicated by a 
short line. Mann-Whitney nonparametric test was used for pair-wise comparison. 
the four amino acid residues inserted in FXR  1 are lo-
cated immediately after the DNA binding domain (DBD). 
The insertion may alter the conformational structure in 
DBD, thus compromising its ability to bind to FXRE. How-
ever, in this study, we showed that FXR  1 and FXR  2 
transactivated human BSEP through two FXREs, IR1b 
and IR1a, respectively. The question remains how FXR  1-
mediated transactivation through IR1b is much weaker 
than FXR  2-mediated activation through IR1a in human 
BSEP. One possible explanation is that FXR  1 might have 
a weaker intrinsic activity than FXR  2. However, such no-
tion is inconsistent with the results that FXR  1 transacti-
vated mouse and rat bsep as potently as did FXR  2 ( Fig. 1 ). 
Another more likely explanation is that the sequence and/
or the content of the IR1b are not optimal for maximal 
activation by FXR  1. 
 Considering that FXR  2-mediated transactivation 
through IR1a is the predominant pathway regulating hu-
man BSEP expression, the question remains regarding 
the physiological signifi cance of FXR  1-mediated trans-
activation through IR1b in regulating human BSEP. One 
possible physiological function of FXR  1/IR1b pathway 
is to support the maximal transactivation of BSEP by the 
FXR  2/IR1a pathway. Consistent with such speculation 
are results from the mutational studies that mutation in 
IR1b markedly reduced FXR  2-mediated basal as well as 
CDCA-induced transactivation of human BSEP ( Fig. 7B ). 
Searching the IR1b sequence in the database revealed 
that IR1b element is present in many promoter regions 
(data not shown). However, it remains to be determined 
whether IR1b element is involved in regulating any of 
those genes. 
 Our results showed that in addition to total FXR levels, 
relative FXR isoform expression levels (FXR  1/FXR  2 
ratios) signifi cantly affected human BSEP expression. In 
healthy human liver tissues, FXR  1/FXR  2 ratios ranged 
from 1.09 to 1.63, with an average of 1.37, while BSEP ex-
pression exhibited 24-fold differences. It was our expecta-
tion that as the FXR  1/FXR  2 ratios increased, BSEP 
expression would decrease. However, the actual data re-
vealed that the relationship between FXR  1/FXR  2 ratio 
and BSEP expression was dependent on the total FXR ex-
pression levels ( Fig. 2A, B ). As expected, human BSEP ex-
pression decreased as the ratios increased at the higher 
levels of total FXR. However, in contrast to our expecta-
tion, BSEP expression increased as the FXR  1/FXR  2 ra-
tio increased at the lower levels of total FXR. We were not 
able to provide a satisfactory explanation for the relation-
ship exhibited at the lower levels of total FXR. Such phe-
nomenon may be related to FXR  1’s specifi c activation 
through IR1b. Since IR1b is completely conserved among 
species, it is reasonable to speculate that FXR  1-mediated 
transactivation of human BSEP through IR1b is critical for 
maintaining BSEP expression in the events of low total 
FXR levels. 
 Although FXR  1 abundantly bound to hIR1a and 
FXR  2 weakly associated with IR1b in vitro in EMSAs ( Fig. 
8A, C ), and FXR  1 competitively decreased FXR  2-
mediated transactivation of IR1a reporter ( Fig. 10A ), it 
was concluded that FXR  1 and FXR  2 did not bind to 
hIR1a and IR1b in the full-length promoter content in in-
tact cells, respectively, based on the following consider-
ations: fi rst, recruitments of FXR  1 to hIR1a and FXR  2 
to IR1b were not detected in intact cells with the ChIP as-
says ( Fig. 9A, B ); second, FXR  1 failed to transactivate 
hIR1a reporter ( Fig. 5A ); and third, overexpression of 
FXR  1 had a negligible effect on FXR  2-mediated trans-
activation of the full-length promoter ( Fig. 10B ), indicat-
ing no competition between the two for binding to IR1a. 
Taken together, the data strongly supported the conclu-
sion that FXR  1 and FXR  2 exclusively bind to IR1b and 
IR1a, respectively, in intact cells. Such discrepancy of FXR 
binding to FXRE between in vitro and in intact cells indi-
cates that FXR binding to FXRE within cells is governed 
not only by the sequence but also by the content. Such no-
tion is supported by the fi nding that among the 1.7 million 
FXREs predicted in the mouse genome, only 1,656 ( 32 ) or 
7,794 ( 30 ) FXREs were detected for FXR binding in vivo 
in the liver. 
 In the ChIP assays, it was noticed that compared with wt 
promoter, the recruitment of FXR  1 to IR1b in the IR1a 
mutant or FXR  2 to IR1a in the IR1b mutant was de-
creased ( Fig. 9A, B ). One possible explanation for such 
phenomenon is that mutation in one site has a negative 
impact on the binding of FXR  1 or FXR  2 to the other 
site due to the proximity of the two sites (18 bases apart). 
It should be noted that the ChIP assays were carried out on 
the transfected wt and mutant promoters. Defi nitive evi-
dence for FXR  1 binding to IR1b or FXR  2 binding to 
IR1a in the endogenous BSEP promoter remains to be 
provided. 
 In contrast to human BSEP, mouse and rat bsep were 
comparably transactivated by FXR  1 and FXR  2 ( Fig. 1 ). 
Mouse and rat m/rIR1a is able to support both FXR  1- 
and FXR  2-mediated transactivation as the FXRE consen-
sus (FXREc: AGGTCA N TGACCT) does (data not shown). 
Comparing the sequences of hIR1a, IR1b, and m/rIR1a 
with FXREc, m/rIR1a is the closest to FXREc, followed by 
IR1b and hIR1a. Detailed analysis of the sequences re-
vealed that a nucleotide G at position 2 is conserved among 
FXREc, m/rIR1a, and hIR1a but altered to T in IR1b. 
Therefore, the G at position 2 may play a determinant role 
in mediating FXR  2 transactivation. On the other hand, 
nucleotides A and T in positions 1 and 13 are conserved 
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among FXREc, m/rIR1a, and IR1b, but they are substi-
tuted with G and C in hIR1a, suggesting that the A and T 
in positions 1 and 13 are important for mediating FXR  1 
transactivation. In this study, we also identifi ed a half ER2 
site immediately upstream of IR1a ( Fig. 5C ). Characteriza-
tion of the ER2 half site revealed that it played an impor-
tant role in achieving maximal transactivation of human 
BSEP by FXR  2, but the site had no effects on FXR  2-
mediated transactivation of rat bsep. Such difference in 
requirement of ER2 for FXR  2 to achieve maximal BSEP 
transactivation may relate to the fact that human hIR1a is 
more remote than mouse/rat m/rIR1a to the FXRE con-
sensus. The imperfect hIR1a needs the half ER2 site to 
support maximal FXR  2 transactivation, whereas the opti-
mal m/rIR1a alone has the capability of fully supporting 
FXR  2 transactivation. 
 In addition to the important role played by FXR in regu-
lating bile acid homeostasis ( 33, 34 ), FXR regulates a myr-
iad of other target genes critical for cholesterol, lipid, and 
glucose homeostasis ( 34–37 ), liver regeneration ( 38 ), and 
tumorigenesis ( 39, 40 ). Based on our new fi nding that 
FXR  1 and FXR  2 transactivated human BSEP through 
two distinct FXREs, it is reasonable to speculate that 
FXR  1 and FXR  2 may preferably regulate different sets 
of FXR target genes involved in various functional path-
ways. We are currently searching for those FXR isoform-
specifi c target genes.  
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